St. Jude Medical Announces the Renewal of Complete Line of Cardiovascular Purchase...

St. Jude Medical Announces the Renewal of Complete Line of Cardiovascular Purchase Agreements with HealthTrust Purchasing Group

ST. PAUL, Minn.--(Business Wire)--St. Jude Medical, Inc. (NYSE:STJ) today announced that it has
renewed its complete line of product agreements with HealthTrust
Purchasing Group, LP (HealthTrust). The renewal will extend through
December 2010 all existing purchasing agreements between the parties,
which cover St. Jude Medical's complete line of Cardiac Rhythm
Management, Atrial Fibrillation, Cardiac Surgery and Cardiology
products.

"We are excited to continue our long-standing partnership with
HealthTrust Purchasing Group and their many equity owners," said
George Fazio, president of St. Jude Medical's U.S. Division. "We are
pleased to support both the physicians and patients who provide and
receive care within all HealthTrust member hospitals during the term
of this agreement."

About HealthTrust Purchasing Group

HealthTrust Purchasing Group, headquartered in Brentwood, Tenn.,
is a group purchasing organization that supports over 3,800
not-for-profit and for-profit facilities including acute care
hospitals, ambulatory surgery centers, physician practices, and
alternate care sites. With an annual purchasing volume by its members
of more than $13 billion, HealthTrust is committed to obtaining the
best price for clinically-recommended products, ensuring their timely
delivery and continuously evaluating and improving its services to the
patients, physicians and clinicians it serves. HealthTrust is located
at 155 Franklin Road, Suite 400, Brentwood, Tenn. 37027 Website:
www.healthtrustpg.com.

About St. Jude Medical

St. Jude Medical is dedicated to making life better for cardiac,
neurological and chronic pain patients worldwide through excellence in
medical device technology and services. The Company has five major
focus areas that include: cardiac rhythm management, atrial
fibrillation, cardiac surgery, cardiology and neuromodulation.
Headquartered in St. Paul, Minn., St. Jude Medical employs
approximately 12,000 people worldwide. For more information, please
visit www.sjm.com.

Forward-Looking Statements

This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 that
involve risks and uncertainties. Such forward-looking statements
include the expectations, plans and prospects for the Company,
including potential clinical successes, anticipated regulatory
approvals and future product launches, and projected revenues,
margins, earnings, and market shares. The statements made by the
Company are based upon management's current expectations and are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company's control and
the risk factors and other cautionary statements described in the
Company's filings with the SEC, including those described in the
Company's Annual Report on Form 10-K filed on February 28, 2007 (see
pages 13-20) and Quarterly Reports on Form 10-Q filed on August 9,
2007 (see pages 28-29) and November 2, 2007 (see pages 23-24). The
Company does not intend to update these statements and undertakes no
duty to any person to provide any such update under any circumstance.

St. Jude Medical, Inc.
Investor Relations:
Angela Craig, 651-481-7789
or
Media Relations:
Kathleen Janasz, 651-415-7042

Copyright Business Wire 2008